Hesse Y, Spraul C W, Lang G K
Universitätsaugenklinik Ulm.
Ophthalmologe. 2002 Dec;99(12):922-6. doi: 10.1007/s00347-002-0690-1.
Infectious endophthalmitis is a serious complication following cataract surgery, since it often induces a substantial reduction of visual acuity.
We retrospectively evaluated the clinical data of 53 patients with endophthalmitis following cataract surgery who were treated at the department of ophthalmology of the University Hospital in Ulm between 1995 and May 2001. Of these patients, 50 had been referred. Clinical presentation, infecting organism, treatment and visual outcome were analysed with a followup ranging from 2 weeks up to 42 months (median: 6 months).
In 52 patients endophthalmitis was preceeded by cataract extraction and IOL implantation, in one case by secondary IOL implantation. Confirmed microbiologic growth was demonstrated from intraocular specimens in 26 out of 41 operated eyes (63%), the most frequent causative organisms were coagulase-negative Staphylococci (50%). All isolated bacteria were sensitive to a combination of the antibiotics vancomycin and amikacin or vancomycin and ceftazidime. 13 patients were treated with intravenous antibiotic therapy alone. In 46% of patients, who were initially treated with intraocular antibiotic injections alone, required further therapeutic intervention for recurrent infection. Only 7.7% of the patients who initially underwent intraocular antibiotic injections combined with IOL removal or pars plana vitrectomy with or without IOL removal, required further surgical intervention. Initial visual acuity was hand movements (median) only but improved during follow-up to 0.2 (median).
In this series all tested bacteria were susceptible to the combination of vancomycin with either amikacin or ceftazidime. Aggressive initial treatment including IOL removal may be associated with a lower frequency of recurrent disease.
感染性眼内炎是白内障手术后的一种严重并发症,因为它常常导致视力大幅下降。
我们回顾性评估了1995年至2001年5月在乌尔姆大学医院眼科接受治疗的53例白内障手术后发生眼内炎患者的临床资料。其中50例为转诊患者。分析了临床表现、感染病原体、治疗方法及视力转归,随访时间为2周至42个月(中位数:6个月)。
52例患者眼内炎发生于白内障摘除及人工晶状体植入术后,1例发生于二期人工晶状体植入术后。41只手术眼中有26只(63%)眼内标本培养出确诊的微生物生长,最常见的病原体是凝固酶阴性葡萄球菌(50%)。所有分离出的细菌对万古霉素与阿米卡星或万古霉素与头孢他啶的联合用药敏感。13例患者仅接受了静脉抗生素治疗。最初仅接受眼内抗生素注射治疗的患者中有46%因感染复发需要进一步的治疗干预。最初接受眼内抗生素注射联合人工晶状体取出术或玻璃体切割术(伴或不伴人工晶状体取出术)的患者中,只有7.7%需要进一步的手术干预。初始视力仅为手动(中位数),但随访期间提高至0.2(中位数)。
在本系列研究中,所有检测的细菌对万古霉素与阿米卡星或头孢他啶的联合用药敏感。积极的初始治疗,包括人工晶状体取出术,可能与较低的疾病复发率相关。